Brief Title
The Asian Transcatheter Aortic Valve Replacement Registry
Official Title
Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Pacific Population
Brief Summary
The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve replacement (TAVR) in the Asian Pacific population
Detailed Description
This registry changes to TP-TAVR registry(NCT03826264). Some subjects moved to TP-TAVR registry and continue to 10-year follow-up.
Study Type
Observational
Primary Outcome
Death
Secondary Outcome
Death from cardiac cause
Condition
Aortic Valve Stenosis
Intervention
transcatheter aortic valve replacement
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Estimated Enrollment
1505
Start Date
December 2014
Completion Date
September 24, 2019
Primary Completion Date
September 24, 2019
Eligibility Criteria
Inclusion Criteria: - Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses - The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
Seung-jung Park, MD, ,
Location Countries
China
Location Countries
China
Administrative Informations
NCT ID
NCT02308150
Organization ID
AMCCV2014-14
Responsible Party
Sponsor-Investigator
Study Sponsor
Seung-Jung Park
Collaborators
CardioVascular Research Foundation, Korea
Study Sponsor
Seung-jung Park, MD, Principal Investigator, Asan Medical Center
Verification Date
September 2019